Providence/St. Joe Cancer Institute/Crosson Cancer Institute — Fullerton, California

Providence/St. Joe Cancer Institute/Crosson Cancer Institute is a clinical research site located in Fullerton, California, United States 92835.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Providence/St. Joe Cancer Institute/Crosson Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Advanced Solid Malignant Tumor.

Sponsors: Chipscreen Biosciences, Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fullerton

Browse all research sites in California · View every site in Fullerton

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence/St. Joe Cancer Institute/Crosson Cancer Institute?

Providence/St. Joe Cancer Institute/Crosson Cancer Institute has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence/St. Joe Cancer Institute/Crosson Cancer Institute conducted?

Providence/St. Joe Cancer Institute/Crosson Cancer Institute has 1 clinical trials on record. Their work covers Small Cell Lung Cancer, Advanced Solid Malignant Tumor.

Is Providence/St. Joe Cancer Institute/Crosson Cancer Institute accredited by Crixeo Clinical Trials?

Providence/St. Joe Cancer Institute/Crosson Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence/St. Joe Cancer Institute/Crosson Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.